246 related articles for article (PubMed ID: 20877571)
1. Light chain separated from the rest of the type a botulinum neurotoxin molecule is the most catalytically active form.
Gul N; Smith LA; Ahmed SA
PLoS One; 2010 Sep; 5(9):e12872. PubMed ID: 20877571
[TBL] [Abstract][Full Text] [Related]
2. Identification of residues surrounding the active site of type A botulinum neurotoxin important for substrate recognition and catalytic activity.
Ahmed SA; Olson MA; Ludivico ML; Gilsdorf J; Smith LA
Protein J; 2008 Apr; 27(3):151-62. PubMed ID: 18213512
[TBL] [Abstract][Full Text] [Related]
3. Catalytic properties of botulinum neurotoxin subtypes A3 and A4.
Henkel JS; Jacobson M; Tepp W; Pier C; Johnson EA; Barbieri JT
Biochemistry; 2009 Mar; 48(11):2522-8. PubMed ID: 19256469
[TBL] [Abstract][Full Text] [Related]
4. High Yield Preparation of Functionally Active Catalytic-Translocation Domain Module of Botulinum Neurotoxin Type A That Exhibits Uniquely Different Enzyme Kinetics.
Dhaliwal HK; Thiruvanakarasu N; Kumar R; Patel K; Ambrin G; Cai S; Singh BR
Protein J; 2017 Dec; 36(6):489-501. PubMed ID: 29030733
[TBL] [Abstract][Full Text] [Related]
5. Structural and biochemical characterization of the protease domain of the mosaic botulinum neurotoxin type HA.
Lam KH; Sikorra S; Weisemann J; Maatsch H; Perry K; Rummel A; Binz T; Jin R
Pathog Dis; 2018 Jun; 76(4):. PubMed ID: 29688327
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the catalytic properties of the botulinum neurotoxin subtypes A1 and A5.
Wang D; Krilich J; Pellett S; Baudys J; Tepp WH; Barr JR; Johnson EA; Kalb SR
Biochim Biophys Acta; 2013 Dec; 1834(12):2722-8. PubMed ID: 24096023
[TBL] [Abstract][Full Text] [Related]
7. The C terminus of the catalytic domain of type A botulinum neurotoxin may facilitate product release from the active site.
Mizanur RM; Frasca V; Swaminathan S; Bavari S; Webb R; Smith LA; Ahmed SA
J Biol Chem; 2013 Aug; 288(33):24223-33. PubMed ID: 23779108
[TBL] [Abstract][Full Text] [Related]
8. Differential endopeptidase activity of different forms of type A botulinum neurotoxin: A unique relationship between the size of the substrate and activity of the enzyme.
Ambrin G; Kumar R; Singh BR
Toxicon; 2018 Mar; 144():34-41. PubMed ID: 29309744
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the functional activity of botulinum neurotoxin subtype B6.
Kohda T; Nakamura K; Hosomi K; Torii Y; Kozaki S; Mukamoto M
Microbiol Immunol; 2017 Nov; 61(11):482-489. PubMed ID: 28898517
[TBL] [Abstract][Full Text] [Related]
10. Expression and purification of catalytically active, non-toxic endopeptidase derivatives of Clostridium botulinum toxin type A.
Chaddock JA; Herbert MH; Ling RJ; Alexander FC; Fooks SJ; Revell DF; Quinn CP; Shone CC; Foster KA
Protein Expr Purif; 2002 Jul; 25(2):219-28. PubMed ID: 12135553
[TBL] [Abstract][Full Text] [Related]
11. High resolution crystal structures of Clostridium botulinum neurotoxin A3 and A4 binding domains.
Davies JR; Rees J; Liu SM; Acharya KR
J Struct Biol; 2018 May; 202(2):113-117. PubMed ID: 29288126
[TBL] [Abstract][Full Text] [Related]
12. The C-terminal heavy-chain domain of botulinum neurotoxin a is not the only site that binds neurons, as the N-terminal heavy-chain domain also plays a very active role in toxin-cell binding and interactions.
Ayyar BV; Aoki KR; Atassi MZ
Infect Immun; 2015 Apr; 83(4):1465-76. PubMed ID: 25624352
[TBL] [Abstract][Full Text] [Related]
13. Light chain of botulinum A neurotoxin expressed as an inclusion body from a synthetic gene is catalytically and functionally active.
Ahmed SA; Smith LA
J Protein Chem; 2000 Aug; 19(6):475-87. PubMed ID: 11195972
[TBL] [Abstract][Full Text] [Related]
14. Molecular dissection of botulinum neurotoxin reveals interdomain chaperone function.
Fischer A; Montal M
Toxicon; 2013 Dec; 75():101-7. PubMed ID: 23396042
[TBL] [Abstract][Full Text] [Related]
15. Structural characterization of three novel hydroxamate-based zinc chelating inhibitors of the Clostridium botulinum serotype A neurotoxin light chain metalloprotease reveals a compact binding site resulting from 60/70 loop flexibility.
Thompson AA; Jiao GS; Kim S; Thai A; Cregar-Hernandez L; Margosiak SA; Johnson AT; Han GW; O'Malley S; Stevens RC
Biochemistry; 2011 May; 50(19):4019-28. PubMed ID: 21434688
[TBL] [Abstract][Full Text] [Related]
16. Structural characterisation of the catalytic domain of botulinum neurotoxin X - high activity and unique substrate specificity.
Masuyer G; Zhang S; Barkho S; Shen Y; Henriksson L; Košenina S; Dong M; Stenmark P
Sci Rep; 2018 Mar; 8(1):4518. PubMed ID: 29540745
[TBL] [Abstract][Full Text] [Related]
17. Unique substrate recognition by botulinum neurotoxins serotypes A and E.
Chen S; Barbieri JT
J Biol Chem; 2006 Apr; 281(16):10906-11. PubMed ID: 16478727
[TBL] [Abstract][Full Text] [Related]
18. Domain organization in Clostridium botulinum neurotoxin type E is unique: its implication in faster translocation.
Kumaran D; Eswaramoorthy S; Furey W; Navaza J; Sax M; Swaminathan S
J Mol Biol; 2009 Feb; 386(1):233-45. PubMed ID: 19118561
[TBL] [Abstract][Full Text] [Related]
19. Single molecule detection of intermediates during botulinum neurotoxin translocation across membranes.
Fischer A; Montal M
Proc Natl Acad Sci U S A; 2007 Jun; 104(25):10447-52. PubMed ID: 17563359
[TBL] [Abstract][Full Text] [Related]
20. Exchanging the minimal cell binding fragments of tetanus neurotoxin in botulinum neurotoxin A and B impacts their toxicity at the neuromuscular junction and central neurons.
Höltje M; Schulze S; Strotmeier J; Mahrhold S; Richter K; Binz T; Bigalke H; Ahnert-Hilger G; Rummel A
Toxicon; 2013 Dec; 75():108-21. PubMed ID: 23817019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]